A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age

Abstract

Patients younger than two years of age predominated, being the main targets for anti-pneumococcal conjugated vaccines. Incidence rates provided evidence of the burden of consolidated pneumonia for childhood, estimating the potential benefits of vaccination.